- A dipstick test for salivary urea nitrogen was accurate for diagnosing kidney disease in adults in Malawi, Africa.
- Results of the test also helped predict patients' risk of early death.
- The test will be described at ASN Kidney Week 2016 November 15-20 at McCormick Place in Chicago, IL.
Chicago, IL (November 18, 2016) -- A simple saliva test may be helpful for diagnosing kidney disease, especially in developing countries. The technology will be highlighted at ASN Kidney Week 2016 November 15¬-20 at McCormick Place in Chicago, IL.
Simple and inexpensive tools for the diagnosis of kidney disease are lacking. Viviane Calice-Silva, MD, PhD (Pro-Kidney Foundation, Brazil) and her colleagues evaluated the diagnostic performance of a salivary urea nitrogen (SUN) dipstick, in Malawi, a low resource country in Africa.
Among 742 individuals who were studied, investigators diagnosed 146 patients with kidney disease using standard tests. High SUN levels were associated not only with the standard diagnostic tests, but also with a higher risk of early death.
"Our data suggest that SUN can improve the detection of kidney disease, increasing the awareness to this devastating complication," said Dr. Calice-Silva. "Also, higher awareness and detection of kidney disease in low resource settings may increase the number of patients who are diagnosed and referred, therefore providing appropriate treatment and improving outcomes."
Study: "Saliva Urea Nitrogen Dipstick: a simple tool to detect and stratify risk of renal disease in low resource settings" (Abstract 5710)
ASN Kidney Week 2016, the largest nephrology meeting of its kind, will provide a forum for more than 13,000 professionals to discuss the latest findings in kidney health research and engage in educational sessions related to advances in the care of patients with kidney and related disorders. Kidney Week 2016 will take place November 15-20, 2016 in Chicago, IL.
The content of this article does not reflect the views or opinions of The American Society of Nephrology (ASN). Responsibility for the information and views expressed therein lies entirely with the author(s). ASN does not offer medical advice. All content in ASN publications is for informational purposes only, and is not intended to cover all possible uses, directions, precautions, drug interactions, or adverse effects. This content should not be used during a medical emergency or for the diagnosis or treatment of any medical condition. Please consult your doctor or other qualified health care provider if you have any questions about a medical condition, or before taking any drug, changing your diet or commencing or discontinuing any course of treatment. Do not ignore or delay obtaining professional medical advice because of information accessed through ASN. Call 911 or your doctor for all medical emergencies.
Since 1966, ASN has been leading the fight to prevent, treat, and cure kidney diseases throughout the world by educating health professionals and scientists, advancing research and innovation, communicating new knowledge, and advocating for the highest quality care for patients. ASN has nearly 16,000 members representing 112 countries. For more information, please visit http://www.